IL64284A - 6-aryl-pyrido(1,4)benzodiazepines and pharmaceutical compositions containing them and intermediates therefor - Google Patents

6-aryl-pyrido(1,4)benzodiazepines and pharmaceutical compositions containing them and intermediates therefor

Info

Publication number
IL64284A
IL64284A IL64284A IL6428481A IL64284A IL 64284 A IL64284 A IL 64284A IL 64284 A IL64284 A IL 64284A IL 6428481 A IL6428481 A IL 6428481A IL 64284 A IL64284 A IL 64284A
Authority
IL
Israel
Prior art keywords
benzodiazepines
pyrido
aryl
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL64284A
Other languages
English (en)
Other versions
IL64284A0 (en
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Priority to IL7451881A priority Critical patent/IL74518A/xx
Publication of IL64284A0 publication Critical patent/IL64284A0/xx
Priority to IL74518A priority patent/IL74518A0/xx
Publication of IL64284A publication Critical patent/IL64284A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL64284A 1981-09-24 1981-11-13 6-aryl-pyrido(1,4)benzodiazepines and pharmaceutical compositions containing them and intermediates therefor IL64284A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL7451881A IL74518A (en) 1981-09-24 1981-11-13 (2-((amino-pyridinyl)amino)phenyl)aryl methanones and pharmaceutical compositions containing them
IL74518A IL74518A0 (en) 1981-09-24 1985-03-06 (2-((amino-pyridinyl)amino)phenyl)aryl methanones and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30508081A 1981-09-24 1981-09-24

Publications (2)

Publication Number Publication Date
IL64284A0 IL64284A0 (en) 1982-02-28
IL64284A true IL64284A (en) 1986-12-31

Family

ID=23179241

Family Applications (1)

Application Number Title Priority Date Filing Date
IL64284A IL64284A (en) 1981-09-24 1981-11-13 6-aryl-pyrido(1,4)benzodiazepines and pharmaceutical compositions containing them and intermediates therefor

Country Status (27)

Country Link
JP (1) JPS5865290A (es)
KR (1) KR890000764B1 (es)
BE (1) BE891666A (es)
CA (1) CA1199324A (es)
CH (1) CH651833A5 (es)
DE (1) DE3150522A1 (es)
DK (3) DK186282A (es)
EG (1) EG15904A (es)
ES (6) ES8303348A1 (es)
FI (1) FI71935C (es)
FR (1) FR2515183B1 (es)
GR (1) GR78473B (es)
HU (2) HU189426B (es)
IE (1) IE52493B1 (es)
IL (1) IL64284A (es)
IN (1) IN156080B (es)
IT (1) IT1146728B (es)
LU (1) LU83865A1 (es)
NL (1) NL8200549A (es)
NO (1) NO157700C (es)
NZ (1) NZ198999A (es)
PH (2) PH17847A (es)
PL (6) PL143596B1 (es)
PT (1) PT74286B (es)
SE (2) SE448629B (es)
YU (1) YU46128B (es)
ZA (1) ZA817866B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825549A (en) * 1972-10-24 1974-07-23 Squibb & Sons Inc Certain dihydropyrido(2,1-b)(1,3)benzodi-azepines and benzodiazocines
DE2424811C3 (de) * 1974-05-22 1981-08-20 Dr. Karl Thomae Gmbh, 7950 Biberach Pyrido-benzodiazepinone, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SE422799B (sv) * 1975-05-28 1982-03-29 Merck & Co Inc Analogiforfarande for framstellning av 1,3-dihydroimidazo (4,5-b)pyridin-2-oner

Also Published As

Publication number Publication date
KR890000764B1 (ko) 1989-04-05
ES8308563A1 (es) 1983-09-16
DK403487D0 (da) 1987-08-03
PL234426A1 (en) 1984-01-02
DK403387D0 (da) 1987-08-03
GR78473B (es) 1984-09-27
BE891666A (fr) 1982-04-16
PL241409A1 (en) 1984-05-21
PL139381B1 (en) 1987-01-31
FR2515183A1 (fr) 1983-04-29
IL64284A0 (en) 1982-02-28
FR2515183B1 (fr) 1986-11-14
IT8168605A0 (it) 1981-12-09
HUT34732A (en) 1985-04-28
FI71935C (fi) 1987-03-09
HU187393B (en) 1985-12-28
IE52493B1 (en) 1987-11-25
NO157700C (no) 1988-05-04
ZA817866B (en) 1982-10-27
SE8600688D0 (sv) 1986-02-17
NO157700B (no) 1988-01-25
ES516051A0 (es) 1983-09-16
YU62582A (en) 1986-04-30
SE8600688L (sv) 1986-02-17
PL143597B1 (en) 1988-02-29
PL143322B1 (en) 1988-02-29
PT74286A (en) 1982-02-01
ES507971A0 (es) 1983-02-01
ES8607726A1 (es) 1986-06-01
HU189426B (en) 1986-07-28
PL241410A1 (en) 1984-01-02
PL138859B1 (en) 1986-11-29
IE812769L (en) 1983-03-24
SE455305B (sv) 1988-07-04
SE448629B (sv) 1987-03-09
EG15904A (en) 1987-03-30
PL143596B1 (en) 1988-02-29
ES543328A0 (es) 1986-06-01
YU46128B (sh) 1993-05-28
ES526563A0 (es) 1986-02-01
IT1146728B (it) 1986-11-19
ES8504148A1 (es) 1985-04-01
SE8106573L (sv) 1983-03-25
CH651833A5 (fr) 1985-10-15
PH17847A (en) 1985-01-09
LU83865A1 (fr) 1983-09-02
NZ198999A (en) 1987-07-31
FI813976L (fi) 1983-03-25
DK403487A (da) 1987-08-03
PH20536A (en) 1987-02-09
JPS5865290A (ja) 1983-04-18
CA1199324A (en) 1986-01-14
NO813839L (no) 1983-03-25
DK403387A (da) 1987-08-03
DE3150522A1 (de) 1983-04-07
PT74286B (en) 1983-06-27
DK186282A (da) 1983-03-25
PL137068B1 (en) 1986-04-30
FI71935B (fi) 1986-11-28
ES8303348A1 (es) 1983-02-01
ES8604531A1 (es) 1986-02-01
ES516052A0 (es) 1984-01-16
ES526562A0 (es) 1985-04-01
ES8402295A1 (es) 1984-01-16
KR830009058A (ko) 1983-12-17
IN156080B (es) 1985-05-11
NL8200549A (nl) 1983-04-18

Similar Documents

Publication Publication Date Title
IL65056A0 (en) Imidazodiazepines,their manufacture and pharmaceutical compositions containing them
IL66099A0 (en) N-aryl-piperazinealkanamides,their preparation and pharmaceutical compositions containing them
DE3267350D1 (en) 5,6,7-trinor-4,8-inter-m-phenylene pgi derivatives and pharmaceutical compositions containing them
IL76405A (en) 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them
IL64847A0 (en) Hexapyranose compounds,their manufacture and pharmaceutical compositions containing them
ZA824622B (en) Pharmaceutical compositions
NZ201520A (en) Substituted aminopyridazines and pharmaceutical compositions
IL66683A0 (en) Benzo-heterocycles,their preparation and pharmaceutical compositions containing them
IL77138A0 (en) Pharmaceutical compositions containing 1-heteroaryl-4-arylpyrazolin-5-ones
IL61930A (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it
ZA859731B (en) Pharmaceutical compositions containing tetrahydrobenzthiazoles
ZA825397B (en) Pharmaceutical compositions
PH23447A (en) B-actam compounds,pharmaceutical compositions containing the same and method of use thereof
ZA822856B (en) Pharmaceutical compositions
IL67284A (en) N-substituted-2-pyridylindoles,their manufacture and pharmaceutical compositions containing them
ZA82652B (en) Pharmaceutical compositions
PH16982A (en) Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide and its pharmaceutical composition
EP0180190A3 (en) 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
JPS57206615A (en) Medicinal composition containing guanfasin
IL65177A0 (en) Fluoroprostacylins,their preparation and pharmaceutical compositions containing them
PH21779A (en) Sulfonomidines and pharmaceutical compositions containing the same
GB8410636D0 (en) Pharmaceutical substances/compositions
PH23343A (en) 8 0( acylaminoergolines and pharmaceutical compositions containing them
IL61862A0 (en) 4,5-diaryl- -(polyhaloalkyl)-1h-imidazole-2-methanols,their preparation and pharmaceutical compositions containing them